Edwards Lifesciences (EW)

Financing Cash Flow

-$1.20B

TTM · Period ending: · USD

EW logo

EW Financing Cash Flow

Latest reported-$1.20B
EW TTM Cash from Financing (-$37.00M → -$1.20B)
High-resolution chart · PNG

EW financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-1,203,000,000
-1,150,000,000
-956,800,000
-916,800,000
-1,153,400,000
-1,302,700,000
-983,000,000
-1,424,800,000
-591,400,000
-442,700,000
-711,000,000
-1,136,200,000
-1,062,800,000
-1,423,000,000
-1,584,500,000
-808,100,000
-699,200,000
-450,100,000
-356,300,000
-252,900,000
-257,900,000
-174,800,000
-486,900,000
-491,300,000
-490,900,000
-746,400,000
-115,600,000
-997,300,000
-1,088,400,000
-1,097,700,000
-1,101,200,000
-485,500,000
-408,500,000
-41,000,000
-473,200,000
-239,100,000
-195,600,000
-290,700,000
-268,500,000
-333,300,000
-373,500,000
-455,800,000
-158,600,000
-53,000,000
-27,900,000
-81,100,000
-153,000,000
-118,400,000
-98,500,000
-84,000,000
34,900,000
-192,500,000
-261,600,000
-177,400,000
-155,600,000
-105,700,000
-184,200,000
-197,800,000
-135,200,000
-64,800,000
-42,400,000
-38,000,000
-103,900,000
-73,400,000
-43,100,000
-44,300,000
-91,800,000
-141,300,000
-107,800,000
-89,400,000
-134,100,000
-106,800,000
-150,100,000
-189,900,000
-108,100,000
-122,100,000
-146,800,000
-165,400,000
-193,600,000
-106,100,000
-79,600,000
-18,100,000
29,000,000
-45,200,000
-67,000,000
-91,200,000
-20,500,000
-27,900,000
2,800,000
30,600,000
-15,000,000
3,500,000
5,900,000
-31,800,000
-69,500,000
-71,500,000
-104,700,000
-98,400,000
-78,000,000
-91,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.